Cargando…
New developments in neurofibromatosis type 2 and vestibular schwannoma
Neurofibromatosis type 2 (NF2) is a rare autosomal dominant disorder characterized by the development of multiple nervous system tumors due to mutation in the NF2 tumor suppressor gene. The hallmark feature of the NF2 syndrome is the development of bilateral vestibular schwannomas (VS). Although the...
Autores principales: | Ren, Yin, Chari, Divya A, Vasilijic, Sasa, Welling, D Bradley, Stankovic, Konstantina M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7881257/ https://www.ncbi.nlm.nih.gov/pubmed/33604573 http://dx.doi.org/10.1093/noajnl/vdaa153 |
Ejemplares similares
-
Identification of Immune-Related Candidate Biomarkers in Plasma of Patients with Sporadic Vestibular Schwannoma: Candidate Plasma Biomarkers in Vestibular Schwannoma
por: Vasilijic, Sasa, et al.
Publicado: (2023) -
Sporadic Vestibular Schwannoma Size and Location Do not Correlate With the Severity of Hearing Loss at Initial Presentation
por: Brown, Alyssa, et al.
Publicado: (2022) -
Computational repositioning and preclinical validation of mifepristone for human vestibular schwannoma
por: Sagers, Jessica E., et al.
Publicado: (2018) -
Publisher Correction: Computational repositioning and preclinical validation of mifepristone for human vestibular schwannoma
por: Sagers, Jessica E., et al.
Publicado: (2018) -
Identification of immune-related candidate biomarkers in plasma of patients with sporadic vestibular schwannoma
por: Vasilijic, Sasa, et al.
Publicado: (2023)